Wentworth Kerry, Chief Regulatory Officer at Nuvation Bio Inc. ($NUVB), made two open market purchases totaling nearly $90,000 in the last year. The most recent buy occurred on June 16, 2025. These purchases rank 2,498th among 4,983 insiders, below the average of about $1.5 million per buyer and 3.3 transactions. Kerry reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Nuvation Bio Inc. | $NUVB | Wentworth Kerry | CHIEF REGULATORY OFFICER | A | Stock Option (Right to Buy) | 748130 | $0.00 | 748,130.0000 | 342,833,433 | 9999.99% | 0.22% |
| June 16, 2025 | Nuvation Bio Inc. | $NUVB | Wentworth Kerry | CHIEF REGULATORY OFFICER | P | Class A Common Stock | 26000 | $1.79 | 26,000.0000 | 337,678,855 | 9999.99% | 0.01% |
| June 16, 2025 | Nuvation Bio Inc. | $NUVB | Wentworth Kerry | CHIEF REGULATORY OFFICER | P | Class A Common Stock | 24000 | $1.80 | 50,000.0000 | 337,678,855 | 92.31% | 0.01% |
| Feb. 28, 2025 | Nuvation Bio Inc. | $NUVB | Wentworth Kerry | CHIEF REGULATORY OFFICER | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 29, 2024 | Nuvation Bio Inc. | $NUVB | Wentworth Kerry | CHIEF REGULATORY OFFICER | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Nuvation Bio Inc. | $NUVB | Wentworth Kerry | Chief Regulatory Officer | A | Stock Option (Right to Buy) | 400000 | $0.00 | 400,000.0000 | 0 | 9999.99% | 0.00% |